The party struggles to hold on in an increasingly diverse borough, even as it fights its own internal battles.
Fear of losing health insurance keeps 1 in 6 U.S. workers in their jobs
Many American workers remain in jobs they’d rather leave—simply because they don’t want to lose their health insurance, a new Gallup poll reveals.
Discovery of a new genetic cause of hearing loss illuminates how inner ear works
A gene called GAS2 plays a key role in normal hearing, and its absence causes severe hearing loss, according to a study led by researchers in the Perelman School of Medicine at the University of Pennsylvania.
Four former Minneapolis police officers are indicted on charges of violating George Floyd’s civil rights.
The charges are another extraordinary censuring of law enforcement officials, who rarely face criminal charges for using deadly force.
Microsoft scraps its next-gen Windows 10X OS to focus on Windows 10 in 2021
Microsoft’s lightweight Windows 10X operating system is not coming in 2021, as the company reportedly wants to focus on regular Windows 10 instead.
New way to reduce scarring
Researchers have been able to reduce scarring by blocking part of the healing process in research that could make a significant difference for burns and other trauma patients.
The Jobs Report: The Boom That Wasn’t
April’s anemic job creation was so out of line with what other indicators have suggested that it will take some time to unravel the mystery.
Why investors are paying attention to elections in Scotland
Investors are waiting for the final results of parliamentary elections in Scotland that could spark radical changes to the political and economic landscape of the United Kingdom.
New antibody rationally designed for better tumor inhibition
Recently, Prof. Xie Can from the High Magnetic Field Laboratory of the Hefei Institutes of Physical Science (HFIPS), in a collaboration with Prof. Yan Xiyun’s lab from the Institute of Biophysics, reported the structural basis of mAb AA98’s inhibition on CD146-mediated endothelial cells (EC) activation and designed higher affinity monoclonal antibody HA98 for cancer treatment.
Two doses of BNT162b2 SARS-CoV-2 vaccine highly effective
Two doses of BNT162b2 are highly effective for preventing symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and other outcomes, according to a study published online May 5 in The Lancet.